SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-433110
Filing Date
2013-11-07
Accepted
2013-11-07 17:07:11
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d594595d10q.htm 10-Q 449711
2 EX-10.1 d594595dex101.htm EX-10.1 54346
3 EX-31.1 d594595dex311.htm EX-31.1 8819
4 EX-31.2 d594595dex312.htm EX-31.2 8818
5 EX-32.1 d594595dex321.htm EX-32.1 4777
  Complete submission text file 0001193125-13-433110.txt   3129462

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nktr-20130930.xml EX-101.INS 348825
7 XBRL TAXONOMY EXTENSION SCHEMA nktr-20130930.xsd EX-101.SCH 38942
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20130930_cal.xml EX-101.CAL 55175
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20130930_def.xml EX-101.DEF 94869
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20130930_lab.xml EX-101.LAB 287364
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20130930_pre.xml EX-101.PRE 186904
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 131201546
SIC: 2834 Pharmaceutical Preparations